Skip to content

Incidence, Clinical Characteristics and Outcomes of Unstable Angina in the contempoRary Area.

Incidence, Clinical Characteristics and Outcomes of Unstable Angina in the contempoRary Area. ICAR Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06378333
Acronym
ICAR
Enrollment
210
Registered
2024-04-22
Start date
2022-11-27
Completion date
2024-04-15
Last updated
2024-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unstable Angina

Keywords

cardiology

Brief summary

The study aims to evaluate clinical characteristics and prognostic of a contemporary population of patients with UA defined using T hs-cTn measurements The study includes all patients admitted in 2 French university centers with the confirmed diagnostic of UA defined with clinical ischemic symptoms and T hs-cTn concentrations \< 99 percentile (undetectable: \<5ng/l or non-elevated: \<14ng/l), or ≥ 99 percentile but mildly elevated (14-50ng/l) .The primary end-point included major events at 1-year follow-up (total mortality, new ACS, hospitalization for cardiac causes).

Interventions

PROCEDUREpatients who underwent coronary angiography

All patients included in the ICAR project (Montpellier - Nîmes) benefit from a consultation at one year (12+or - 2 months), as they are systematically reviewed in our department: data will therefore be collected in the patient's medical record. Clinical biological parameters and events during the hospital phase are also collected in the patient's computerized record. Normal patient management remains unchanged.

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Patients with ischemic symptoms at rest or minor exercise without evidence of acute myocardial necrosis. * Ischemic symptoms may include typical or atypical angina pectoris and worsening/deterioration of previously stable angina with or without electrical signs of ischemia on the electrocardiogram. * hs-cTn concentrations are in the normal range or may be slightly elevated \> 99th percentile (i.e. low troponin T elevation ≤ 50 \* Elecsys Roche) but with absence of significant kinetics according to criteria defined in the literature (\<20%). * One of the following angiographic criteria is required: * Coronary angiography revealing a stenosis with a diameter of at least 70%. * Stenosis of at least 50% diameter in the left common trunk. * FFR (Fractional Flow Reserve) documenting ischemia per coronary angiography of a coronary lesion in the case of intermediate stenosis (50-70%). * If there are no significant lesions, a spasm must be proven by an ergonovine test.

Exclusion criteria

* NSTEMI and STEMI. * Coronaries normal or without significant lesions unless proven spasm.

Design outcomes

Primary

MeasureTime frame
Number of patients with hospitalisation for unstable anginaOne year after hospitalisation for of unstable Angina

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026